You just read:

Glenmark Pharmaceuticals to Initiate Clinical Study for GBR 1342, Second Investigational New Drug from Immuno-Oncology Portfolio

News provided by

Glenmark Pharmaceuticals

May 15, 2017, 08:00 ET